Acquired Dysplastic Melanocytic Nevi and Cutaneous Melanoma: Precursors and Prevention
Authors: ARTHUR R. RHODES
Journal: Annals of Internal Medicine (1985)

Editorials1 April 1985Acquired Dysplastic Melanocytic Nevi and Cutaneous Melanoma: Precursors and PreventionARTHUR R. RHODES, M.D.ARTHUR R. RHODES, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-102-4-546 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptCutaneous melanoma is a potentially lethal tumor of melanocytes. It has been estimated that in 1984, 18 000 persons in the United States developed melanoma and 5500 of them died from metastatic disease (1). Persons who are white, have a personal or family history of cutaneous melanoma, sunburn easily and tan poorly, have had excessive sun exposure in the first decade of life, and have increased numbers of large and irregularly pigmented moles are at greatly increased risk of developing cutaneous melanoma (2-5). The study by Greene and colleagues (6) focuses on the relation between familial cutaneous melanoma and the...References1. SILVERBERG E. Cancer statistics, 1984; CA. 1984;34:7-23. Google Scholar2. RHODES A, SOBER A, MIHM M, and FITZPATRICK T. Possible risk factors for primary cutaneous malignant melanoma [Abstract]. Clin Res. 1980;28:252A. Google Scholar3. DUGGLEBY W, STOLL H, PRIORE R, GREENWALD P, and GRAHAM S. A genetic analysis of melanoma—polygenetic inheritance as a threshold trait. Am J Epidemiol. 1981;114:63-72. CrossrefMedlineGoogle Scholar4. HOLMAN C and ARMSTRONG B. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. JNCI. 1984;73:75-82. MedlineGoogle Scholar5. D'ARCY C, HOLMAN C, and ARMSTRONG B. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. JNCI. 1984;72:257-66. MedlineGoogle Scholar6. GREENE M, CLARK W, TUCKER M, KRAEMER K, ELDER D, and FRASER R. The prospective diagnosis of malignant melanoma in a population at high risk: hereditary melanoma and the dysplastic nevus syndrome. Ann Intern Med. 1985;102:458-65. LinkGoogle Scholar7. ELDER D, GREENE M, BONDI E, and CLARK W. Acquired melanocytic nevi and melanoma: the dysplastic nevus syndrome. In: ACKERMAN AB, ed. Pathology of Malignant Melanoma. New York: Masson Publishing USA, Inc.; 1981:185-215. Google Scholar8. SWERDLOW A, ENGLISH J, MACKIE R, O'DOHERTY C, HUNTER J, and CLARK J. Benign naevi associated with high risk of melanoma [Letter]. Lancet. 1984;2:168. CrossrefMedlineGoogle Scholar9. RHODES A. Pigmented birthmarks and precursor melanocytic lesions of cutaneous melanoma identifiable in childhood. Pediatr Clin North Am. 1983;30:435-63. CrossrefMedlineGoogle Scholar10. RHODES A, MELSKI J, SOBER A, HARRIST T, MIHM M, and FITZPATRICK T. Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma: a comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines. J Invest Dermatol. 1983;80:452-9. CrossrefMedlineGoogle Scholar11. GREENE M, CLARK W, and TUCKER M. Acquired precursors of cutaneous malignant melanoma: the familial dysplastic nevus syndrome. N Engl J Med. 1985;312:91-7. CrossrefMedlineGoogle Scholar12. LYNCH H, FRICHOT B, and LYNCH J. Familial atypical multiple mole-melanoma syndrome. J Med Genet. 1978;15:352-6. CrossrefMedlineGoogle Scholar13. CLARK W, REIMER R, GREENE M, AINSWORTH A, and MASTRANGELO M. Origin of familial malignant melanomas from heritable melanocytic lesions: the B-K mole syndrome. Arch Dermatol. 1978;114:732-8. CrossrefMedlineGoogle Scholar14. ALLEN A and SPITZ S. Malignant melanoma: a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer. 1953;6:1-45. CrossrefMedlineGoogle Scholar15. MUNRO D. Multiple active junctional naevi with family history of malignant melanoma. Proc R Soc Med. 1974;67:594-5. MedlineGoogle Scholar16. NORRIS W. A case of fungoid disease. Edinb Med Surg J. 1820;16:562-5. MedlineGoogle Scholar17. ELDER D, GOLDMAN L, GOLDMAN S, GREENE M, and CLARK W Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer. 1980;46:1787-94. CrossrefMedlineGoogle Scholar18. HAGSTROM W, FAIBISOFF B, SOLTANI K, and ROBSON M. Dysplastic nevus syndrome (B-K mole syndrome). Plast Reconstr Surg. 1983;71:219-24. CrossrefMedlineGoogle Scholar19. WHITE I and MACDONALD D. Familial multiple melanocytic naevi—the B-K mole syndrome. Clin Exp Dermatol. 1981;6:549-53. CrossrefMedlineGoogle Scholar20. KRAEMER K, GREENE M, TARONE R, ELDER D, CLARK W, and GUERRY D. Dysplastic naevi and cutaneous melanoma risk [Letter]. Lancet 1983;2:1076-7. CrossrefMedlineGoogle Scholar21. TUCKER M, MISFELDT D, COLEMAN C, CLARK W, and ROSENBERG S. Cutaneous malignant melanoma after Hodgkin's disease. Ann Intern Med. 1985;102:37-41. LinkGoogle Scholar22. FLANNERY J and HONEYMAN M. Cancer incidence and mortality in Connecticut, 1973-77. In: YOUNG JL, PERCY CL, ASIRE AJ, eds. Surveillance, Epidemiology, and End Results: Incidence and Mortality Data, 1973-77. Natl Cancer Inst Monogr. 1981;(57): 189-217. (NIH publication no. 81-2330). Google Scholar23. RHODES A, HARRIST T, DAY C, MIHM M, FITZPATRICK T, and SOBER A. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol. 1983;9:563-74. CrossrefMedlineGoogle Scholar24. SOBER A, DAY C, and KOH H. Melanoma in the northeastern United States: experience of the Melanoma Clinical Cooperative group. In: BALCH CM, MILTON GW, eds. Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide. Philadelphia: J. B. Lippincott Company; 1985:389-95. Google Scholar25. BALCH C, SOONG S, and MILTON G. Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia. Cancer. 1983;52:1748-53. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: ARTHUR R. RHODES, M.D.Affiliations: The Children's Hospital Harvard Medical School Boston, Massachusetts PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDysplastic Nevi Versus MelanomaMelanozytäre Nävi und MelanomvorläuferPigmentzellnävi und MelanomvorläuferSensitivity and Specificity of Self-examination for Cutaneous Malignant Melanoma Risk FactorsThe detection and management of dysplastic nevi and early melanomaProspective Follow-Up for Malignant Melanoma in Patients with Atypical-Mole (Dysplastic-Nevus) SyndromeClinical characteristics of malignant melanomas developing in persons with dysplastic neviProgression of Neoplasms Deriving from Pigmented TissuesAbnormal nevi, excess total nevi, and melanoma: an epidemiologic perspectiveRoutine total skin examination to detect malignant melanomaDiagnosis of the dysplastic nevus in different populationsBeobachtungen, Überlegungen und Fragen zu dysplastischen Naevi 1 April 1985Volume 102, Issue 4Page: 546-548KeywordsCutaneous melanomaMelanoma ePublished: 1 December 2008 Issue Published: 1 April 1985 PDF downloadLoading ...